SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Seaport Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$17.79−0.04 (-0.22%)
Close on Oct 19, 2026
- Market cap
- $626.85M
- P/E (TTM)
- –
- Dividend yield
- –
About Seaport Therapeutics
Pharmaceutical Preparations, SIC 2834
Seaport Therapeutics, Inc. is listed on Nasdaq under the ticker SPTX, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.
Company profile
Company
- Legal name
- Seaport Therapeutics, Inc.
- Headquarters
- Boston, MA
- Address
- 6 Tide Street, Suite 400 02110
- Phone
- (617) 807-4062
- Website
- seaporttx.com
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- SPTX
- Exchange
- Nasdaq
- IPO date
- May 1, 2026
- Shares outstanding
- 54M, Jul 27, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2042347
- CUSIP
- 81221K108
- ISIN
- US81221K1088
- EIN
- 99-2235719
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Daphne Zohar | Chief Executive Officer, Director | 1,194,001 |
| Lana Gladstein | General Counsel | 33,515 |
| Michael Cunyuan Chen | Chief Scientific Officer | 3,351 |
| Lauren White | Chief Financial Officer | 6,702 |
| Antony Loebel | Chief Medical Officer | 20,109 |
| Robert J. Hombach | Director | 13,000 |
| General Atlantic (SP), L.P. | Director | – |
| Gap Coinvestments Iii, Llc | Director | – |
| General Atlantic, L.P. | Director | – |
| GAP Coinvestments CDA, L.P. | Director | – |
| Gap Coinvestments Iv, Llc | Director | – |
| (Bermuda) L.P. GAP | Director | – |
| General Atlantic Genpar (Bermuda), L.P. | Director | – |
| General Atlantic Genpar, L.P. | Director | – |
| GAP Coinvestments V, LLC | Director | – |
| General Atlantic (SPV) GP, LLC | Director | 6,101,582 |
| Atlantic GenPar (Lux) SCSp General | Director | 6,101,582 |
| General Atlantic Partners (Lux), SCSp | Director | – |
| General Atlantic Partners 100, L.P. | Director | – |
| Atlantic (Lux) S.a r.l. General | Director | – |
| David E. Wheadon | Director | – |
| Denice Torres | Director | 13,406 |
| Sandra E. Peterson | Director | – |
| Steven M. Paul | Director | 863,031 |
| Sharon Mates | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 1, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Apr 28, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |